BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35491797)

  • 1. A Randomized, Double-Blinded Crossover Trial of Short Versus Conventional Pulse Width Subthalamic Deep Brain Stimulation in Parkinson's Disease.
    Petry-Schmelzer JN; Gerus L; Jergas H; Reker P; Steffen JK; Dafsari HS; Baldermann JC; Fink GR; Visser-Vandewalle V; Dembek TA; Barbe MT
    J Parkinsons Dis; 2022; 12(5):1497-1505. PubMed ID: 35491797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Versus Conventional Pulse-Width Deep Brain Stimulation in Parkinson's Disease: A Randomized Crossover Comparison.
    Dayal V; Grover T; Tripoliti E; Milabo C; Salazar M; Candelario-McKeown J; Athauda D; Zrinzo L; Akram H; Hariz M; Limousin P; Foltynie T
    Mov Disord; 2020 Jan; 35(1):101-108. PubMed ID: 31571270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech.
    Fabbri M; Natale F; Artusi CA; Romagnolo A; Bozzali M; Giulietti G; Guimaraes I; Rizzone MG; Accornero A; Lopiano L; Zibetti M
    Parkinsonism Relat Disord; 2021 Jun; 87():130-134. PubMed ID: 34034153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind study.
    Bouthour W; Wegrzyk J; Momjian S; Péron J; Fleury V; Tomkova Chaoui E; Horvath J; Boëx C; Lüscher C; Burkhard PR; Krack P; Zacharia A
    Mov Disord; 2018 Jan; 33(1):169-173. PubMed ID: 29266392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined STN/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial.
    Weiss D; Wächter T; Meisner C; Fritz M; Gharabaghi A; Plewnia C; Breit S; Krüger R
    Trials; 2011 Oct; 12():222. PubMed ID: 21989388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Short Pulse Width Settings on the Therapeutic Window in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's disease.
    Dayal V; Grover T; Limousin P; Akram H; Cappon D; Candelario J; Salazar M; Tripoliti E; Zrinzo L; Hyam J; Jahanshahi M; Hariz M; Foltynie T
    J Parkinsons Dis; 2018; 8(2):273-279. PubMed ID: 29843252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson's disease: a study protocol.
    Zoon TJC; van Rooijen G; Contarino MF; van der Gaag S; Zutt R; van Asseldonk JT; van den Munckhof P; Schuurman PR; Denys DAJP; de Bie RMA
    Trials; 2024 Feb; 25(1):104. PubMed ID: 38308317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Deep Brain Stimulation of the Subthalamic Nucleus Settings on Voice Quality, Intensity, and Prosody in Parkinson's Disease: Preliminary Evidence for Speech Optimization.
    Abeyesekera A; Adams S; Mancinelli C; Knowles T; Gilmore G; Delrobaei M; Jog M
    Can J Neurol Sci; 2019 May; 46(3):287-294. PubMed ID: 30905324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directional versus ring-mode deep brain stimulation for Parkinson's disease: protocol of a multi-centre double-blind randomised crossover trial.
    Brinke TRT; Jergas H; Sisodia V; Barbe MT; Odekerken VJJ; Verbaan D; Dijk JM; Bot M; Beudel M; van den Munckhof P; Schuurman PR; de Bie RMA
    BMC Neurol; 2023 Oct; 23(1):372. PubMed ID: 37853327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep brain stimulation with short versus conventional pulse width in Parkinson's disease and essential tremor: A systematic review and meta-analysis.
    Smeets S; Boogers A; Van Bogaert T; Peeters J; McLaughlin M; Nuttin B; Theys T; Vandenberghe W; De Vloo P
    Brain Stimul; 2024; 17(1):71-82. PubMed ID: 38160999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson's Disease.
    Udupa K; Bahl N; Ni Z; Gunraj C; Mazzella F; Moro E; Hodaie M; Lozano AM; Lang AE; Chen R
    J Neurosci; 2016 Jan; 36(2):396-404. PubMed ID: 26758832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease.
    Hidding U; Gulberti A; Pflug C; Choe C; Horn A; Prilop L; Braaß H; Fründt O; Buhmann C; Weiss D; Westphal M; Engel AK; Gerloff C; Köppen JA; Hamel W; Moll CKE; Pötter-Nerger M
    Parkinsonism Relat Disord; 2019 May; 62():141-147. PubMed ID: 30616868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated deep brain stimulation programming based on electrode location: a randomised, crossover trial using a data-driven algorithm.
    Roediger J; Dembek TA; Achtzehn J; Busch JL; Krämer AP; Faust K; Schneider GH; Krause P; Horn A; Kühn AA
    Lancet Digit Health; 2023 Feb; 5(2):e59-e70. PubMed ID: 36528541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
    Jiang L; Chen W; Guo Q; Yang C; Gu J; Xian W; Liu Y; Zheng Y; Ye J; Xu S; Hu Y; Wu L; Chen J; Qian H; Fu X; Liu J; Chen L
    CNS Neurosci Ther; 2021 Nov; 27(11):1366-1373. PubMed ID: 34350691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.
    Okun MS; Fernandez HH; Wu SS; Kirsch-Darrow L; Bowers D; Bova F; Suelter M; Jacobson CE; Wang X; Gordon CW; Zeilman P; Romrell J; Martin P; Ward H; Rodriguez RL; Foote KD
    Ann Neurol; 2009 May; 65(5):586-95. PubMed ID: 19288469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short Pulse and Conventional Deep Brain Stimulation Equally Improve the Parkinsonian Gait Disorder.
    Seger A; Gulberti A; Vettorazzi E; Braa H; Buhmann C; Gerloff C; Hamel W; Moll CKE; Pötter-Nerger M
    J Parkinsons Dis; 2021; 11(3):1455-1464. PubMed ID: 34057096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.